Lesly Robinson, DPM
Podiatrist · Wilmington, DENPI 1629081922
Payments from drug & device makers
What this record shows
22 manufacturers reported payments, led by Osiris Therapeutics Inc. at 46.4% of the total. Reporting peaked in 2019 at $1,767 and has fallen 71.8% since, to $498 in 2025.
Across 91 payments — averaging $36.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osiris Therapeutics Inc.$2K
- Smith+Nephew$768
- Organogenesis Inc.$305
- Kerecis Limited$147
- Reapplix Inc.$58
- AstraZeneca$58
- plus $427 from 16 others
Across 17 payments — averaging $5830.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$87K
- Osiris Therapeutics Inc.$12K
What the payments were for
- Speaking & faculty fees$1,50046%
- Food & beverage$1,78954%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osiris Therapeutics Inc. | 3 | $1,526 |
| Smith+Nephew | 50 | $768 |
| Organogenesis Inc. | 12 | $305 |
| Kerecis Limited | 1 | $147 |
| Reapplix Inc. | 2 | $58 |
| AstraZeneca | 2 | $58 |
| Solventum Corporation | 2 | $50 |
| Bristol Myers Squibb | 2 | $45 |
| BTG International Inc. | 2 | $42 |
| Integra Lifesciences Corporation | 2 | $41 |
| Nevro Corp. | 2 | $37 |
| Medtronic | 1 | $35 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Stryker | 1 | $22 |
| Amgen | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $20 |
| Urgo Medical North America, LLC | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Hartmann USA, Inc. | 1 | $15 |
| 3M Company | 1 | $14 |
| Misonix Inc | 1 | $14 |
| Fusion Orthopedics USA, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$1,500
- Grafix$1,500
- GrafixPL$1,500
- Kerecis SurgiClose$589
- Kerecis GraftGuide$147
- GRAFIX PL$146
- Oasis$146
How this compares
$3,289 in reported general payments places this provider in the 70th percentile of 37 podiatrist providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 179 | $4,319 |
| Ammonium Lactate | 122 | $2,521 |
| Ketoconazole | 127 | $2,473 |
| Clindamycin Phosphate | 13 | $337 |
| CiclopiroxCiclopirox Olamine | 12 | $222 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $184 |
| Duloxetine Hcl | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Wilmington
- Harold GruberWilmington$10K
- Lahari MadulapallyWilmington$9K
- Brian McDermottWilmington$7K
- Sandra HudakWilmington$2K
- Anmol BurmiWilmington$2K
- Luis GarciaWilmington$1K
- Lori LarueWilmington$501
- Christopher SavageWilmington$473
- Michael HenryWilmington$316
- Michael HaagWilmington$273
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.